Cargando…
Aptamers with Self-Loading Drug Payload and pH-Controlled Drug Release for Targeted Chemotherapy
Doxorubicin (DOX) is a common anti-tumor drug that binds to DNA or RNA via non-covalent intercalation between G-C sequences. As a therapeutic agent, DOX has been used to form aptamer–drug conjugates for targeted cancer therapy in vitro and in vivo. To improve the therapeutic potential of aptamer–DOX...
Autores principales: | Zeng, Zihua, Qi, Jianjun, Wan, Quanyuan, Zu, Youli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398837/ https://www.ncbi.nlm.nih.gov/pubmed/34452182 http://dx.doi.org/10.3390/pharmaceutics13081221 |
Ejemplares similares
-
Aptamer–Gemcitabine Conjugates with Enzymatically Cleavable Linker for Targeted Delivery and Intracellular Drug Release in Cancer Cells
por: Qi, Jianjun, et al.
Publicado: (2022) -
Aptamer Cocktail to Detect Multiple Species of Mycoplasma in Cell Culture
por: Wan, Quanyuan, et al.
Publicado: (2020) -
Aptamer Targets Triple-Negative Breast Cancer through Specific Binding to Surface CD49c
por: Wan, Quanyuan, et al.
Publicado: (2022) -
Oligonucleotide aptamers for pathogen detection and infectious disease control
por: Wan, Quanyuan, et al.
Publicado: (2021) -
Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy
por: Zeng, Zihua, et al.
Publicado: (2020)